PointState Capital LP Q4 2021 Filing

Filed February 11, 2022

Portfolio Value

$6.0T

Holdings

104

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (104 positions)

#StockSharesValue% PortfolioType
101
BNTXBIONTECH SE
3,908$1.0B0.02%
102
I9DNARBUTUS BIOPHARMA CORP
200,000$778.0M0.01%
103
NEENEXTERA ENERGY INC
6,778$633.0M0.01%
104
—OUTLOOK THERAPEUTICS INC
100,000$10.0M0.00%
PreviousPage 2 of 2